Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.

Arndt Hartmann, John C. Cheville, Wolfgang Dietmaier, Ferdinand Hofstädter, Lawrence J. Burgart, Hagen Blaszyk

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Urothelial carcinoma of the upper urinary tract is relatively uncommon but may develop as a manifestation of the hereditary nonpolyposis colorectal cancer syndrome (HNPCC), which is characterized by mutations in a number of DNA mismatch repair genes and detectable as microsatellite instability or loss of the respective protein by immunostaining. No well-established screening test is available for urothelial carcinomas of the upper urinary tract, and little is known of the clinical impact of screening for HNPCC in patients with upper urinary tract cancer. We describe herein a patient with a urothelial carcinoma of the ureter and a strongly positive history of cancer, who was subsequently found to have HNPCC. Our findings reinforce the importance of obtaining a comprehensive history of cancer in patients with urothelial carcinoma of the renal pelvis and ureter. Subsequent identification of individuals with HNPCC enables the patient and at-risk relatives to benefit from targeted surveillance and management programs.

Original languageEnglish (US)
JournalArchives of Pathology and Laboratory Medicine
Volume127
Issue number2
StatePublished - 2003
Externally publishedYes

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Carcinoma
Ureter
Urinary Tract
Urologic Neoplasms
Microsatellite Instability
Kidney Pelvis
DNA Mismatch Repair
Neoplasms
Mutation
Genes
Proteins

Cite this

Hartmann, A., Cheville, J. C., Dietmaier, W., Hofstädter, F., Burgart, L. J., & Blaszyk, H. (2003). Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Archives of Pathology and Laboratory Medicine, 127(2).

Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. / Hartmann, Arndt; Cheville, John C.; Dietmaier, Wolfgang; Hofstädter, Ferdinand; Burgart, Lawrence J.; Blaszyk, Hagen.

In: Archives of Pathology and Laboratory Medicine, Vol. 127, No. 2, 2003.

Research output: Contribution to journalArticle

Hartmann, A, Cheville, JC, Dietmaier, W, Hofstädter, F, Burgart, LJ & Blaszyk, H 2003, 'Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.', Archives of Pathology and Laboratory Medicine, vol. 127, no. 2.
Hartmann, Arndt ; Cheville, John C. ; Dietmaier, Wolfgang ; Hofstädter, Ferdinand ; Burgart, Lawrence J. ; Blaszyk, Hagen. / Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. In: Archives of Pathology and Laboratory Medicine. 2003 ; Vol. 127, No. 2.
@article{733d79c3a848402b9ab04803ccd0619e,
title = "Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.",
abstract = "Urothelial carcinoma of the upper urinary tract is relatively uncommon but may develop as a manifestation of the hereditary nonpolyposis colorectal cancer syndrome (HNPCC), which is characterized by mutations in a number of DNA mismatch repair genes and detectable as microsatellite instability or loss of the respective protein by immunostaining. No well-established screening test is available for urothelial carcinomas of the upper urinary tract, and little is known of the clinical impact of screening for HNPCC in patients with upper urinary tract cancer. We describe herein a patient with a urothelial carcinoma of the ureter and a strongly positive history of cancer, who was subsequently found to have HNPCC. Our findings reinforce the importance of obtaining a comprehensive history of cancer in patients with urothelial carcinoma of the renal pelvis and ureter. Subsequent identification of individuals with HNPCC enables the patient and at-risk relatives to benefit from targeted surveillance and management programs.",
author = "Arndt Hartmann and Cheville, {John C.} and Wolfgang Dietmaier and Ferdinand Hofst{\"a}dter and Burgart, {Lawrence J.} and Hagen Blaszyk",
year = "2003",
language = "English (US)",
volume = "127",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "2",

}

TY - JOUR

T1 - Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.

AU - Hartmann, Arndt

AU - Cheville, John C.

AU - Dietmaier, Wolfgang

AU - Hofstädter, Ferdinand

AU - Burgart, Lawrence J.

AU - Blaszyk, Hagen

PY - 2003

Y1 - 2003

N2 - Urothelial carcinoma of the upper urinary tract is relatively uncommon but may develop as a manifestation of the hereditary nonpolyposis colorectal cancer syndrome (HNPCC), which is characterized by mutations in a number of DNA mismatch repair genes and detectable as microsatellite instability or loss of the respective protein by immunostaining. No well-established screening test is available for urothelial carcinomas of the upper urinary tract, and little is known of the clinical impact of screening for HNPCC in patients with upper urinary tract cancer. We describe herein a patient with a urothelial carcinoma of the ureter and a strongly positive history of cancer, who was subsequently found to have HNPCC. Our findings reinforce the importance of obtaining a comprehensive history of cancer in patients with urothelial carcinoma of the renal pelvis and ureter. Subsequent identification of individuals with HNPCC enables the patient and at-risk relatives to benefit from targeted surveillance and management programs.

AB - Urothelial carcinoma of the upper urinary tract is relatively uncommon but may develop as a manifestation of the hereditary nonpolyposis colorectal cancer syndrome (HNPCC), which is characterized by mutations in a number of DNA mismatch repair genes and detectable as microsatellite instability or loss of the respective protein by immunostaining. No well-established screening test is available for urothelial carcinomas of the upper urinary tract, and little is known of the clinical impact of screening for HNPCC in patients with upper urinary tract cancer. We describe herein a patient with a urothelial carcinoma of the ureter and a strongly positive history of cancer, who was subsequently found to have HNPCC. Our findings reinforce the importance of obtaining a comprehensive history of cancer in patients with urothelial carcinoma of the renal pelvis and ureter. Subsequent identification of individuals with HNPCC enables the patient and at-risk relatives to benefit from targeted surveillance and management programs.

UR - http://www.scopus.com/inward/record.url?scp=0037317324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037317324&partnerID=8YFLogxK

M3 - Article

C2 - 12562253

AN - SCOPUS:0037317324

VL - 127

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 2

ER -